Generic Name and Formulations:
Cromolyn sodium 100mg/5mL; oral concentrate; preservative-free.
Indications for GASTROCROM:
Mix contents of amp in water and drink. ≥13yrs: 200mg 4 times daily, at regular intervals, ½ hour before meals and at bedtime; may increase if insufficient response within 2–3 weeks. Max 40mg/kg per day; maintain at lowest effective dose.
Mix contents of amp in water and drink. <2yrs: usually not recommended; see literature. 2–12yrs: 100mg 4 times daily, at regular intervals, ½ hour before meals and at bedtime; may increase if insufficient response within 2–3 weeks. Max 40mg/kg per day; maintain at lowest effective dose.
Renal or hepatic dysfunction, reduce dose. Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Headache, GI upset, pruritus, myalgia, rash, irritability, malaise.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|